September 5, 2025

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Robust 119% Upside Potential

Delcath Systems, Inc. (NASDAQ: DCTH), a leader in the healthcare sector specializing in medical devices, is capturing investor attention with its promising treatment solutions for liver cancers. The company, headquartered..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 54% Potential Upside in the Diagnostics Sector

Investors eyeing opportunities in the healthcare sector should take a closer look at Castle Biosciences, Inc. (NASDAQ: CSTL), a key player in the diagnostics and research industry. With a market..

LifeMD, Inc. (LFMD) Stock Analysis: A Telehealth Pioneer with 105% Potential Upside

For investors keen on the burgeoning telehealth sector, LifeMD, Inc. (NASDAQ: LFMD) presents an intriguing opportunity. Specializing in direct-to-patient healthcare services, LifeMD operates through its Telehealth and WorkSimpli segments, providing..

Mind Medicine (MNMD) Stock Analysis: Exploring a Potential 170% Upside with Promising Biotech Innovations

Investors with a keen eye on the rapidly evolving biotech sector may find Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) an intriguing opportunity. This clinical-stage biopharmaceutical company, with a market capitalization..

Kura Oncology, Inc. (KURA) Stock Analysis: A Biotech with 232% Potential Upside and Strong Buy Ratings

Kura Oncology, Inc. (NASDAQ: KURA) is a clinical-stage biopharmaceutical company making significant strides in the biotechnology sector. With a focus on developing innovative cancer treatments, Kura’s pipeline is spearheaded by..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a 235% Potential Upside Amidst Challenges

Vir Biotechnology, Inc. (NASDAQ: VIR) has been a topic of interest for investors looking to capitalize on the healthcare sector’s innovative edge. As a clinical-stage biopharmaceutical company, Vir Biotechnology is..

GH Research PLC (GHRS) Stock Analysis: Uncovering a Potential 133.60% Upside in the Biotech Sector

GH Research PLC (NASDAQ: GHRS), a prominent player in the biotechnology sector, is garnering significant attention from investors with its promising pipeline and substantial potential upside. Based in Dublin, Ireland,..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Cannabis Market with Caution Amid a 16.24% Downside

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the healthcare sector’s niche of drug manufacturers specializing in cannabinoids, presents a mixed bag for investors seeking exposure to the burgeoning..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Potential Upside of 63.48% Amid Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, OrthoPediatrics Corp. (NASDAQ: KIDS) presents a compelling case. Specializing in medical devices tailored for pediatric orthopedic conditions, the company is positioned within..

Claritev Corporation (CTEV) Stock Analysis: Navigating Growth with a 4.2% Potential Upside

Claritev Corporation (NASDAQ: CTEV) stands at a pivotal juncture within the healthcare sector, specifically in health information services. With a market capitalization of $1.11 billion, Claritev is a key player..

CeriBell, Inc. (CBLL) Stock Analysis: A 143% Potential Upside in the Transformative Medical Devices Sector

CeriBell, Inc. (NASDAQ: CBLL) is carving a niche within the healthcare sector, specifically in the medical devices industry, by advancing the diagnosis and management of serious neurological conditions. Headquartered in..

Opthea Limited (OPT) Stock Analysis: Evaluating the -70.67% Potential Downside Amidst Clinical Progress

Opthea Limited (OPT), a prominent player in the biotechnology sector, is making headlines with its focus on developing innovative treatments for eye diseases. Headquartered in Melbourne, Australia, Opthea is on..

Valneva SE (VALN) Investor Outlook: Exploring a 54.69% Potential Upside in the Biotech Space

Valneva SE (NASDAQ: VALN), a French specialty vaccine company, is capturing attention in the biotechnology sector with its promising portfolio of prophylactic vaccines. Trading at $8.84, Valneva’s current market dynamics..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Potential 112% Upside Sparks Investor Interest

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company headquartered in New York, is gaining traction among investors, largely due to its promising pipeline in the treatment of severe autoimmune..

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Biotech Play with Nearly 48% Upside Potential

Keros Therapeutics, Inc. (NASDAQ: KROS) stands out as an intriguing opportunity within the healthcare sector, particularly in the biotechnology industry. With a market capitalization of $631.57 million, this clinical-stage biopharmaceutical..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unveiling a Potential 246.80% Upside in the Biotechnology Sector

Capricor Therapeutics, Inc. (NASDAQ: CAPR) stands as a promising player in the biotechnology sector, gaining attention with a potential upside of 246.80% based on current analyst ratings. As a clinical-stage..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a Potential 67.88% Upside in the Rare Disease Market

Eton Pharmaceuticals, Inc. (ETON), a key player in the healthcare sector focusing on rare diseases, is gaining attention from investors due to its promising growth potential and significant upside. Based..

Oculis Holding AG (OCS): Analyst Consensus Points to 118% Upside in Biotech Innovator

Oculis Holding AG (OCS) is drawing significant attention from investors looking to capitalize on its promising pipeline in the biotechnology sector. Based in Zug, Switzerland, Oculis is a clinical-stage biopharmaceutical..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring a 102.64% Potential Upside in Biotechnology

ArriVent BioPharma, Inc. (AVBP) stands out in the biotechnology sector with its promising pipeline and strategic approach to address unmet medical needs in cancer treatment. Despite its clinical-stage status, the..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges with Strategic Workforce Solutions

AMN Healthcare Services Inc (NYSE: AMN), a prominent player in the healthcare workforce solutions sector, stands at a pivotal point in its market journey. With a current market cap of..

Search

Funds

September 5, 2025

Search

Funds

September 5, 2025

FTSE 100

Funds